Massachusetts Financial Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-36,514
Closed -$6.87M 856
2023
Q1
$6.87M Sell
36,514
-19,623
-35% -$4.06M ﹤0.01% 630
2022
Q4
$11.9M Buy
56,137
+10,222
+22% +$2.04M ﹤0.01% 593
2022
Q3
$7.22M Buy
45,915
+36,689
+398% +$5.85M ﹤0.01% 634
2022
Q2
$1.38M Buy
+9,226
New +$1.34M ﹤0.01% 756
2020
Q3
Sell
-10,680
Closed -$993K 890
2020
Q2
$993K Sell
10,680
-6,618
-38% -$563K ﹤0.01% 741
2020
Q1
$1.27M Buy
17,298
+2,738
+19% +$238K ﹤0.01% 719
2019
Q4
$1.22M Buy
+14,560
New +$1.13M ﹤0.01% 750
2017
Q2
Sell
-452,555
Closed -$13.5M 874
2017
Q1
$13.5M Buy
452,555
+144,815
+47% +$4.67M 0.01% 552
2016
Q4
$11.1M Sell
307,740
-752
-0.2% -$25K 0.01% 577
2016
Q3
$9.21M Buy
+308,492
New +$9.01M ﹤0.01% 591

Other funds holding MEDP

Massachusetts Financial Services's MEDP Position: Q2 2023 in Review

Massachusetts Financial Services sold out of Medpace (MEDP) in Q2 2023, closing a stake of 36,514 shares — an estimated $6.87M sold.

Massachusetts Financial Services first reported a position in MEDP in Q3 2016 and held it in 10 quarters. The position peaked at $13.5M in Q1 2017. 462 funds tracked by Wall St. Rank hold MEDP as of Q2 2023.

  • Massachusetts Financial Services reported no remaining Medpace position as of Q2 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 36,514 Medpace shares in Q2 2023, an estimated $6.87M.
  • Massachusetts Financial Services first reported a position in Medpace in Q3 2016 and held it in 10 quarters.
  • Massachusetts Financial Services's Medpace position peaked at $13.5M in Q1 2017.
  • 462 funds tracked by Wall St. Rank held Medpace as of Q2 2023.

Based on Massachusetts Financial Services's 13F filing for Q2 2023, filed 9 Aug 2023.